Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
Authors
Keywords
-
Journal
Future Microbiology
Volume 6, Issue 6, Pages 653-666
Publisher
Future Medicine Ltd
Online
2011-06-28
DOI
10.2217/fmb.11.49
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Bactericidal Activity of Three Different Dosing Regimens of Colistin with Implications for Optimum Clinical Use
- (2014) G.L. Daikos et al. JOURNAL OF CHEMOTHERAPY
- In VitroInteractions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development
- (2011) Maria Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase
- (2011) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in France
- (2011) Gaelle Cuzon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
- (2011) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Adaptive resistance to cationic compounds in Pseudomonas aeruginosa
- (2011) Anna Skiada et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
- (2011) G. Meletis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Does broad-spectrum -lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
- (2011) P. Nordmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aerosol Delivery of Antimicrobial Agents During Mechanical Ventilation: Current Practice and Perspectives
- (2011) Argyris Michalopoulos et al. Current Drug Delivery
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii
- (2010) M. M. Sopirala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Penem-1 in Combination with -Lactams against blaKPC-Possessing Klebsiella pneumoniae Isolates
- (2010) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extremely Drug-ResistantCitrobacter freundiiIsolate Producing NDM-1 and Other Carbapenemases Identified in a Patient Returning from India
- (2010) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa
- (2010) B. Layeux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin-Resistant Clinical Isolates ofEscherichiacoli
- (2010) Carl Urban et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae
- (2010) B. Kitchel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Metallo- -Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia
- (2010) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftazidime and NXL104 in Two Murine Models of Infection Due to KPC-ProducingKlebsiella pneumoniae
- (2010) Andrea Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
- (2010) A. Carrer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae
- (2010) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Dissemination of NDM-1- and OXA-181-ProducingEnterobacteriaceaein Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007
- (2010) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of Colistin-Resistant, Carbapenem-ResistantKlebsiella pneumoniaein Metropolitan Detroit, Michigan
- (2010) Dror Marchaim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Susceptibility to Various Antibiotics of Colistin‐Resistant Gram‐Negative Bacterial Isolates in a General Tertiary Hospital in Crete, Greece
- (2010) George Samonis et al. CLINICAL INFECTIOUS DISEASES
- Tigecycline and Bacteremia—The Dangers of Post Hoc Analysis of Pooled Data
- (2010) Giorgio Tarchini CLINICAL INFECTIOUS DISEASES
- Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study
- (2010) Diamantis P. Kofteridis et al. CLINICAL INFECTIOUS DISEASES
- Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
- (2010) Y. Carmeli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes
- (2010) May Nguyen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Resistance to polymyxins: Mechanisms, frequency and treatment options
- (2010) Matthew E. Falagas et al. DRUG RESISTANCE UPDATES
- Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary
- (2010) Á. Tóth et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- New β-lactam antibiotics and β-lactamase inhibitors
- (2010) Karen Bush et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Natural History of Colonization with Gram-Negative Multidrug-Resistant Organisms among Hospitalized Patients
- (2010) Amy C. Weintrob et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The Antibiotic Development Pipeline for Multidrug-Resistant Gram-Negative Bacilli: Current and Future Landscapes
- (2010) George H. Talbot INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
- (2010) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2
- (2010) A. Zioga et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns
- (2010) Volker Strenger et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin
- (2010) M. Vaara et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model
- (2010) M. Souli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 -lactamase
- (2010) T. Naas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo- -lactamase
- (2010) A. Poulou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
- (2010) P. Rattanaumpawan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem Heteroresistance in VIM-1-Producing Klebsiella pneumoniae Isolates Belonging to the Same Clone: Consequences for Routine Susceptibility Testing
- (2010) M. Tato et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
- (2010) A. Elemam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K. pneumoniae
- (2010) S. Pournaras et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae: a Matched Case-Control Study
- (2010) O. Zarkotou et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Global spread of New Delhi metallo-β-lactamase 1
- (2010) Laurent Poirel et al. LANCET INFECTIOUS DISEASES
- Antimicrobial Susceptibility Patterns of KPC-Producing or CTX-M-Producing Enterobacteriaceae
- (2010) Mariana Castanheira et al. Microbial Drug Resistance
- Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
- (2009) G. L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates
- (2009) A. M. Nicasio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Regional Dissemination of KPC-Producing Klebsiella pneumoniae
- (2009) B. Kitchel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
- (2009) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo- -Lactamase-Producing Klebsiella pneumoniae Isolates?
- (2009) M. Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
- (2009) D. Yong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interspecies Spread ofKlebsiella pneumoniaeCarbapenemase Gene in a Single Patient
- (2009) Hanna E. Sidjabat et al. CLINICAL INFECTIOUS DISEASES
- Infection with PanresistantKlebsiella pneumoniae:A Report of 2 Cases and a Brief Review of the Literature
- (2009) Azza Elemam et al. CLINICAL INFECTIOUS DISEASES
- An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
- (2009) Maria Souli et al. CLINICAL INFECTIOUS DISEASES
- Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials
- (2009) David Gardiner et al. CLINICAL INFECTIOUS DISEASES
- Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
- (2009) I.P. Korbila et al. CLINICAL MICROBIOLOGY AND INFECTION
- Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
- (2009) A. Michalopoulos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study
- (2009) Dimitrios K. Matthaiou et al. CRITICAL CARE MEDICINE
- Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
- (2009) Matthew Falagas et al. CURRENT DRUG METABOLISM
- Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem
- (2009) Scott A. Weisenberg et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
- (2009) Nikos Roussos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult
- (2009) Shmuel Benenson et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Liposomes as delivery systems for antibiotics
- (2009) Zuzanna Drulis-Kawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin
- (2009) J. Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City
- (2009) S. Bratu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections with VIM-1 Metallo- -Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome
- (2009) M. Falcone et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection
- (2009) J. Lee et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
- (2009) Garyphallia Poulakou et al. JOURNAL OF INFECTION
- Adjustment of dosing of antimicrobial agents for bodyweight in adults
- (2009) Matthew E Falagas et al. LANCET
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
- (2009) Patrice Nordmann et al. LANCET INFECTIOUS DISEASES
- Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
- (2009) Matthew E Falagas et al. LANCET INFECTIOUS DISEASES
- Fatal cross infection by carbapenem-resistantKlebsiellain two liver transplant recipients
- (2009) A.J. Mathers et al. Transplant Infectious Disease
- Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens
- (2008) S. J. Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-Mediated 16S rRNA Methylases among Extended-Spectrum -Lactamase-Producing Enterobacteriaceae Isolates
- (2008) B. Bercot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States
- (2008) S. Navon-Venezia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey
- (2008) A. Carrer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline
- (2008) K. B. Anthony et al. CLINICAL INFECTIOUS DISEASES
- Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections
- (2008) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Clinical Experience of Serious Infections Caused by Enterobacteriaceae Producing VIM-1 Metallo- -Lactamase in a Greek University Hospital
- (2008) M. Souli et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
- (2008) Nikolaos Markou et al. CLINICAL THERAPEUTICS
- Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin
- (2008) M. E. Falagas et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
- (2008) Gopi Patel et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
- (2008) Theodoros Kelesidis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
- (2008) A. Poudyal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
- (2008) E. Llobet et al. MICROBIOLOGY-SGM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now